Patents by Inventor AIHONG ZHANG

AIHONG ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250041336
    Abstract: The present disclosure provides new anti-cancer immune cells engineered to express chimeric receptors which, unlike the conventional chimeric antigen receptors (CAR), employ the extracellular domain of a receptor that binds a ligand which may be expressed on a target tumor cell. The immune cell is preferably an immature myeloid cell that is p50 deficient. Such an engineered immune cell exhibits improved therapeutic efficacy as compared to the conventional immune cell therapies and is more broadly applicable to different types of cancers.
    Type: Application
    Filed: September 28, 2022
    Publication date: February 6, 2025
    Inventors: Aihong ZHANG, Douglas FALK
  • Publication number: 20250017969
    Abstract: The present disclosure provides methods for preparing immune cells that express a chimeric receptor. The immune cells, preferably p50 deficient immature myeloid cells, exhibited improved therapeutic efficacy as compared to the conventional immune cell therapies and are more broadly applicable to different types of cancers. The preparation methods preferably include inactivating p50 in a progenitor cell, expanding the cell under hypoxic conditions, transducing a polynucleotide that encodes the chimeric receptor, and differentiating the engineered progenitor cell to an immature myeloid cell.
    Type: Application
    Filed: November 28, 2022
    Publication date: January 16, 2025
    Inventors: Aihong ZHANG, Amir SABERI, Douglas FALK, Peter ANDERSEN, Daniel J. GRUN
  • Publication number: 20250009880
    Abstract: The present disclosure provides new anti-cancer immune cells engineered to express chimeric receptors which, unlike the conventional chimeric antigen receptors (CAR), employ the extracellular domain of PD-1 that is capable of binding PD-L1 that is expressed on a target tumor cell. The immune cell is preferably an immature myeloid cell that is p50 deficient. Such an engineered immune cell exhibits improved therapeutic efficacy as compared to the conventional immune cell therapies and is more broadly applicable to different types of cancers expressing, or induced to express PD-L1.
    Type: Application
    Filed: November 28, 2022
    Publication date: January 9, 2025
    Inventors: Aihong ZHANG, Amir SABERI, Douglas FALK, Peter ANDERSEN, Kayla Myers CHEN
  • Patent number: 12037584
    Abstract: An isolated polynucleotide includes: (a) a polynucleotide sequence as shown in SEQ ID NO: 1; or (b) a polynucleotide sequence comprising at least 15 or 17 or 19 or 21 contiguous nucleotides of SEQ ID NO: 1, wherein the ingestion, by Coleoptera insect pests, of a double-stranded RNA comprising at least one strand complementary to the polynucleotide sequence inhibits the growth of the Coleoptera insect pests; or (c) any one of the polynucleotide sequence as shown in SEQ ID NO: 3 to SEQ ID NO: 6; or (d) a polynucleotide sequence hybridized with the polynucleotide sequence defined in (a), (b) or (c) mentioned above under stringent conditions. Multiple target sequences of the target gene c46312 control the Coleoptera insect pest Monolepta hieroglyphica.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: July 16, 2024
    Assignee: BEIJING DABEINONG BIOTECHNOLOGY CO., LTD.
    Inventors: Aihong Zhang, Derong Ding, Qing Tao, Xiaojiao Li
  • Publication number: 20230257766
    Abstract: Related is a use of an insecticidal protein. The insecticidal protein may be used to control a thrip pest. A method for controlling the a thrip pest includes: allowing the a thrip pest to be at least in contact with an ACh1 protein. In the present application, the a thrip pest is controlled through producing the ACh1 protein that can kill the a thrip pest in bacteria and/or a plant in vivo.
    Type: Application
    Filed: December 7, 2022
    Publication date: August 17, 2023
    Inventors: Tengyu CHANG, Qinyang WANG, Aihong ZHANG, Qing TAO
  • Publication number: 20230220412
    Abstract: Related is a use of an insecticidal protein. The insecticidal protein may be used to control Monolepta hieroglyphica (Motschulsky). A method for controlling the Monolepta hieroglyphica (Motschulsky) includes: allowing the Monolepta hieroglyphica (Motschulsky) to be at least in contact with an ACe1 protein. In the present application, the ACe1 protein that can kill the Monolepta hieroglyphica (Motschulsky) is produced in bacteria and/or a plant body to control the Monolepta hieroglyphica (Motschulsky).
    Type: Application
    Filed: December 8, 2022
    Publication date: July 13, 2023
    Inventors: Tengyu CHANG, Qinyang WANG, Aihong ZHANG, Qing TAO
  • Publication number: 20230212602
    Abstract: Related is a use of an insecticidal protein. The insecticidal protein may be used to control Monolepta hieroglyphica (Motschulsky). A method for controlling the Monolepta hieroglyphica (Motschulsky) includes: allowing the Monolepta hieroglyphica (Motschulsky) to be at least in contact with an ACh1 protein. In the present application, the Monolepta hieroglyphica (Motschulsky) is controlled through producing the ACh1 protein that can kill the Monolepta hieroglyphica (Motschulsky) in bacteria and/or a plant in vivo.
    Type: Application
    Filed: December 8, 2022
    Publication date: July 6, 2023
    Inventors: Tengyu CHANG, Qinyang WANG, Aihong ZHANG, Qing TAO
  • Publication number: 20230180767
    Abstract: Related is a use of an insecticidal protein. The insecticidal protein may be used to control Ostrinia furnacalis (Hubern). A method for controlling Ostrinia furnacalis (Hubern) includes: allowing the Ostrinia furnacalis (Hubern) to be at least in contact with an ACe1 protein. In the present application, the ACe1 protein that can kill the Ostrinia furnacalis (Hubern) is produced in bacteria and/or a plant body to control the Ostrinia furnacalis (Hubern).
    Type: Application
    Filed: December 7, 2022
    Publication date: June 15, 2023
    Inventors: Tengyu CHANG, Qinyang WANG, Aihong ZHANG, Qing TAO
  • Publication number: 20230183736
    Abstract: Related is a use of an insecticidal protein. The insecticidal protein may be used to control Apolygus lucorum. A method for controlling the Apolygus lucorum includes: allowing the Apolygus lucorum to be at least in contact with an ACh1 protein. In the present application, the ACh1 protein that can kill the Apolygus lucorum is produced in bacteria and/or a plant in vivo to control the Apolygus lucorum.
    Type: Application
    Filed: December 6, 2022
    Publication date: June 15, 2023
    Inventors: Tengyu CHANG, Qinyang WANG, Aihong ZHANG, Qing TAO
  • Patent number: 11613749
    Abstract: An isolated polynucleotide includes: (a) a polynucleotide sequence as shown in SEQ ID NO: 1; or (b) a polynucleotide sequence having at least 15, 17, 19 or 21 contiguous nucleotides of SEQ ID NO: 1, wherein the growth of a pest of the order Coleoptera is inhibited when the pest of the order Coleoptera ingests double-stranded RNA comprising at least one strand that is complementary to the described polynucleotide sequence; or (c) any polynucleotide sequence as shown in SEQ ID NO: 3 to SEQ ID NO: 6; or (d) a polynucleotide sequence which hybridizes under stringent conditions with the polynucleotide sequence as defined in (a), (b) or (c). A plurality of target sequences are used for controlling a target gene c4506 of Monolepta hieroglyphica, which is a pest of the order Coleoptera.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: March 28, 2023
    Inventors: Aihong Zhang, Derong Ding, Qing Tao, Xiaojiao Li
  • Patent number: 11505805
    Abstract: Provided are an isolated polynucleotide and a method for controlling insect invasion. The isolated polynucleotide is a plurality of target sequences for controlling target gene c35112 of a coleopteran pest, Monolepta hieroglyphica, comprising: a) a polynucleotide sequence shown as SEQ ID NO: 1; or (b) a polynucleotide sequence having at least 15 or 17 or 19 or 21 contiguous nucleotides of SEQ ID NO: 1, a double-stranded RNA comprising at least one strand complementary to the polynucleotide sequence being capable of inhibiting the growth of coleopteran pests after being ingested by the coleopteran pests; or (c) any one of polynucleotide sequences shown as SEQ ID NO: 3 to SEQ ID NO: 20; or (d) a polynucleotide sequence that hybridizes under stringent conditions to a polynucleotide sequence as defined in (a), (b) or (c).
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: November 22, 2022
    Assignee: BEIJING DABEINONG BIOTECHNOLOGY CO., LTD.
    Inventors: Aihong Zhang, Derong Ding, Qing Tao, Xiaojiao Li
  • Publication number: 20220054608
    Abstract: Described herein are agents and methods for targeting antigen-specific B cells using engineered T cells, such as regulatory T cells or cytotoxic T cells, or bi-specific antibodies. The agents and methods can be used to reduce undesirable immune responses.
    Type: Application
    Filed: July 29, 2021
    Publication date: February 24, 2022
    Inventors: David W. SCOTT, Yongchan KIM, Aihong ZHANG
  • Patent number: 11090373
    Abstract: Described herein are agents and methods for targeting antigen-specific B cells using engineered T cells, such as regulatory T cells or cytotoxic T cells, or bi-specific antibodies. The agents and methods can be used to reduce undesirable immune responses.
    Type: Grant
    Filed: October 6, 2016
    Date of Patent: August 17, 2021
    Assignee: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: David W. Scott, Yongchan Kim, Aihong Zhang
  • Publication number: 20210246445
    Abstract: An isolated polynucleotide includes: (a) a polynucleotide sequence as shown in SEQ ID NO: 1; or (b) a polynucleotide sequence comprising at least 15 or 17 or 19 or 21 contiguous nucleotides of SEQ ID NO: 1, wherein the ingestion, by Coleoptera insect pests, of a double-stranded RNA comprising at least one strand complementary to the polynucleotide sequence inhibits the growth of the Coleoptera insect pests; or (c) any one of the polynucleotide sequence as shown in SEQ ID NO: 3 to SEQ ID NO: 6; or (d) a polynucleotide sequence hybridized with the polynucleotide sequence defined in (a), (b) or (c) mentioned above under stringent conditions. Multiple target sequences of the target gene c46312 control the Coleoptera insect pest Monolepta hieroglyphica.
    Type: Application
    Filed: May 29, 2019
    Publication date: August 12, 2021
    Inventors: Aihong ZHANG, Derong DING, Qing TAO, Xiaojiao LI
  • Publication number: 20210246444
    Abstract: An isolated polynucleotide includes: (a) a polynucleotide sequence as shown in SEQ ID NO: 1; or (b) a polynucleotide sequence having at least 15, 17, 19 or 21 contiguous nucleotides of SEQ ID NO: 1, wherein the growth of a pest of the order Coleoptera is inhibited when the pest of the order Coleoptera ingests double-stranded RNA comprising at least one strand that is complementary to the described polynucleotide sequence; or (c) any polynucleotide sequence as shown in SEQ ID NO: 3 to SEQ ID NO: 6; or (d) a polynucleotide sequence which hybridizes under stringent conditions with the polynucleotide sequence as defined in (a), (b) or (c). A plurality of target sequences are used for controlling a target gene c4506 of Monolepta hieroglyphica, which is a pest of the order Coleoptera.
    Type: Application
    Filed: May 29, 2019
    Publication date: August 12, 2021
    Inventors: Aihong ZHANG, Derong DING, Qing TAO, Xiaojiao LI
  • Publication number: 20210214744
    Abstract: Provided are an isolated polynucleotide and a method for controlling insect invasion. The isolated polynucleotide is a plurality of target sequences for controlling target gene c35112 of a coleopteran pest, Monolepta hieroglyphica, comprising: a) a polynucleotide sequence shown as SEQ ID NO: 1; or (b) a polynucleotide sequence having at least 15 or 17 or 19 or 21 contiguous nucleotides of SEQ ID NO: 1, a double-stranded RNA comprising at least one strand complementary to the polynucleotide sequence being capable of inhibiting the growth of coleopteran pests after being ingested by the coleopteran pests; or (c) any one of polynucleotide sequences shown as SEQ ID NO: 3 to SEQ ID NO: 20; or (d) a polynucleotide sequence that hybridizes under stringent conditions to a polynucleotide sequence as defined in (a), (b) or (c).
    Type: Application
    Filed: May 7, 2019
    Publication date: July 15, 2021
    Inventors: Aihong ZHANG, Derong DING, Qing TAO, Xiaojiao LI
  • Patent number: 10676741
    Abstract: Disclosed are a nucleotide sequence and a method for controlling insect invasions, the isolated polynucleotide sequence comprising: (a) a polynucleotide sequence as shown in SEQ ID NO: 1, 2 or 3; or (b) a polynucleotide sequence hybridizing with the polynucleotide sequence defined in (a) under stringent conditions; or (c) a polynucleotide sequence having an identity of not less than 80% to the polynucleotide sequence defined in (a); or (d) a polynucleotide sequence of at least 19 consecutive nucleotides of the polynucleotide sequence defined in (a), wherein a double-stranded RNA comprising at least one strand complementary to the polynucleotide sequence, when ingested by an insect pest from Hemiptera, inhibits growth of the insect pest; or (e) a complementary sequence of the polynucleotide sequence as defined in (a), (b), (c) or (d). The three target sequences for controlling an insect pest from Hemiptera, Lygus, have the advantages of efficiency, specificity, convenience and low cost.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: June 9, 2020
    Assignee: BEIJING DABEINONG BIOTECHNOLOGY CO., LTD.
    Inventors: Derong Ding, Aihong Zhang
  • Publication number: 20190367912
    Abstract: Disclosed are a nucleotide sequence and a method for controlling insect invasions, the isolated polynucleotide sequence comprising: (a) a polynucleotide sequence as shown in SEQ ID NO: 1, 2 or 3; or (b) a polynucleotide sequence hybridizing with the polynucleotide sequence defined in (a) under stringent conditions; or (c) a polynucleotide sequence having an identity of not less than 80% to the polynucleotide sequence defined in (a); or (d) a polynucleotide sequence of at least 19 consecutive nucleotides of the polynucleotide sequence defined in (a), wherein a double-stranded RNA comprising at least one strand complementary to the polynucleotide sequence, when ingested by an insect pest from Hemiptera, inhibits growth of the insect pest; or (e) a complementary sequence of the polynucleotide sequence as defined in (a), (b), (c) or (d). The three target sequences for controlling an insect pest from Hemiptera, Lygus, have the advantages of efficiency, specificity, convenience and low cost.
    Type: Application
    Filed: December 9, 2016
    Publication date: December 5, 2019
    Applicant: BEIJING DABEINONG BIOTECHNOLOGY CO., LTD.
    Inventors: Derong DING, Aihong ZHANG
  • Publication number: 20180369350
    Abstract: Described herein are agents and methods for targeting antigen-specific B cells using engineered T cells, such as regulatory T cells or cytotoxic T cells, or bi-specific antibodies. The agents and methods can be used to reduce undesirable immune responses.
    Type: Application
    Filed: October 6, 2016
    Publication date: December 27, 2018
    Applicant: The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
    Inventors: David W. Scott, Yongchan KIM, Aihong ZHANG
  • Patent number: 8916688
    Abstract: The invention relates to an insecticidal protein, its gene encoding and the uses thereof. The protein comprises: (a) a protein consisting of an amino acid sequence shown by SEQ ID NO:2 or a sequence of amino acid residuses at positions 1 to 640 thereof; or (b) a protein derived from (a) by substitution, deletion, or addition of one or more amino acid residuses of the amino acid sequences in (a), and having insecticidal activity; or (c) a protein generated by the expression of nucleic acid molecules containing a sequence of amino acid residuses at the positions 1 to 1920 of SEQ ID NO:1; or (d) a protein generated by the expression of nucleic acid molecules containing a complementary sequence that hybridized with the sequence of nucleotides at the positions 1 to 1920 of SEQ ID NO:1 under stringent conditions. The protein has high expression level and strong toxicity against pests.
    Type: Grant
    Filed: March 18, 2013
    Date of Patent: December 23, 2014
    Assignees: Beijing Green Agrosino Plant Protection Technology Co., Ltd., Beijing Dabeinong Technology Group Co., Ltd., Biotech Center, Beijing Dabeinong Technology Group Co., Ltd.
    Inventors: Aihong Zhang, Jie Pang, Ruiqi Niu, Lihong Niu, Chao Gao, Mengmeng Miao, Donghai Yang